Daily Stock Analysis, BIOC, Biocept Inc, priceseries

Biocept Inc. Daily Stock Analysis
Stock Information
Open
0.95
Close
0.98
High
0.98
Low
0.85
Previous Close
0.95
Daily Price Gain
0.03
YTD High
3.72
YTD High Date
Jan 16, 2019
YTD Low
0.84
YTD Low Date
Jan 2, 2019
YTD Price Change
0.00
YTD Gain
0.00%
52 Week High
12.15
52 Week High Date
Jul 13, 2018
52 Week Low
0.66
52 Week Low Date
Dec 17, 2018
52 Week Price Change
-5.90
52 Week Gain
-85.75%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jan 5. 2017
27.00
Jan 18. 2017
46.42
8 Trading Days
71.91%
Link
LONG
Jan 24. 2017
50.70
Jan 25. 2017
53.55
1 Trading Days
5.62%
Link
LONG
Feb 7. 2017
47.10
Feb 17. 2017
59.11
8 Trading Days
25.51%
Link
LONG
May 29. 2018
5.78
Jun 21. 2018
6.99
17 Trading Days
20.97%
Link
LONG
Oct 26. 2018
2.33
Oct 29. 2018
2.48
1 Trading Days
6.22%
Link
LONG
Jan 14. 2019
2.20
Jan 15. 2019
2.38
1 Trading Days
7.95%
Link
LONG
Jan 16. 2019
2.34
Jan 18. 2019
2.55
2 Trading Days
8.97%
Link
LONG
Jan 24. 2019
2.04
Jan 25. 2019
2.19
1 Trading Days
7.11%
Link
Company Information
Stock Symbol
BIOC
Exchange
NasdaqCM
Company URL
http://www.biocept.com
Company Phone
858-320-8200
CEO
Michael W. Nall
Headquarters
California
Business Address
5810 NANCY RIDGE DR, SAN DIEGO, CA 92121
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Laboratories & Research
CIK
0001044378
About

Biocept, Inc. is an oncology laboratory service company, which focuses on the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA tests utilizing a standard blood sample. The company utilizes cell enrichment and extraction technology for the detection and analysis of circulating tumor DNA tests. It also offers services to other laboratory testing providers, academic institutions, research organizations, biopharmaceutical companies and clinical trial support. Biocept was founded on May 12, 1997 and is headquartered in San Diego, CA.

Description

Biocept, Inc., an early stage molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. The company's cancer assays provide information to oncologists and other physicians that enable them to select personalized treatment for their patients who have been diagnosed with cancer based on molecular drivers. It offers assays for solid tumor indications, such as breast cancer, non-small cell lung cancer, small cell lung cancer, gastric cancer, colorectal cancer, prostate cancer, and melanoma. The company sells its cancer diagnostic assays directly to oncologists and other physicians at private and group practices, hospitals, and cancer centers in the United States, as well as markets its clinical trial and research services to pharmaceutical and biopharmaceutical companies, and clinical research organizations. Biocept, Inc. was founded in 1997 and is headquartered in San Diego, California.